Skip to Content
Merck
  • The photodynamic therapy on Streptococcus mutans biofilms using erythrosine and dental halogen curing unit.

The photodynamic therapy on Streptococcus mutans biofilms using erythrosine and dental halogen curing unit.

International journal of oral science (2012-12-12)
Young-Ho Lee, Ho-Won Park, Ju-Hyun Lee, Hyun-Woo Seo, Si-Young Lee
ABSTRACT

The purpose of our study was to evaluate the effect of photodynamic therapy (PDT), using erythrosine as a photosensitizing agent and a dental halogen curing unit as a light source, on Streptococcus mutans in a biofilm phase. The S. mutans biofilms were formed in a 24-well cell culture cluster. Test groups consisted of biofilms divided into four groups: group 1: no photosensitizer or light irradiation treatment (control group); group 2: photosensitizer treatment alone; group 3: light irradiation alone; group 4: photosensitizer treatment and light irradiation. After treatments, the numbers of colony-forming unit (CFU) were counted and samples were examined by confocal laser scanning fluorescence microscopy (CLSM). Only group 4 (combined treatment) resulted in significant increases in cell death, with rates of 75% and 55% after 8 h of incubation, and 74% and 42% at 12 h, for biofilms formed in brain-heart infusion (BHI) broth supplemented with 0% or 0.1% sucrose, respectively. Therefore, PDT of S. mutans biofilms using a combination of erythrosine and a dental halogen curing unit, both widely used in dental clinics, resulted in a significant increase in cell death. The PDT effects are decreased in biofilms that form in the presence of sucrose.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Erythrosin B, certified by the Biological Stain Commission, Dye content ≥85 %
Sigma-Aldrich
Erythrosin extra bluish, certified by the Biological Stain Commission
Sigma-Aldrich
Erythrosin extra bluish, for microscopy (Bact., Hist.), adsorption and fluorescent indicator
Supelco
Erythrosin B, analytical standard